Resistin, obesity, and insulin resistance--the emerging role of the adipocyte as an endocrine organ.
about
Fortifying the Treatment of Prostate Cancer with Physical ActivityObesity and reproductive functionMaturation of human neutrophil phagosomes includes incorporation of molecular chaperones and endoplasmic reticulum quality control machinery.Type 2 diabetes mellitus phenotype and graft survival after islet transplantationLoss of P2X7 nucleotide receptor function leads to abnormal fat distribution in mice.Dominant inhibitory adipocyte-specific secretory factor (ADSF)/resistin enhances adipogenesis and improves insulin sensitivity.The search for new ways to treat obesity.The Role of Adipokines in Understanding the Associations between Obesity and Depression.Glucocorticoids exacerbate obesity and insulin resistance in neuron-specific proopiomelanocortin-deficient mice.Circulating cortisol-associated signature of glucocorticoid-related gene expression in subcutaneous fat of obese subjects.Role of high-fat diet in stress response of Drosophila.Cardiac-specific leptin receptor deletion exacerbates ischaemic heart failure in mice.Intracellular trafficking and secretion of adiponectin is dependent on GGA-coated vesicles.Adiponectin: a manifold therapeutic target for metabolic syndrome, diabetes, and coronary disease?Serum resistin level in obese male childrenAdipose tissue quantification by imaging methods: a proposed classification.Serum adiposity-induced biomarkers in obese and lean children with recently diagnosed autoimmune type 1 diabetesLifestyle modification and endothelial function in obese subjects.Adipose tissue signaling by nuclear receptors in metabolic complications of obesityRising risk of type 2 diabetes among inhabitants of Jamnagar, Gujarat: A cross-sectional survey.Insulin resistance: a proinflammatory state mediated by lipid-induced signaling dysfunction and involved in atherosclerotic plaque instabilityPPARs and the kidney in metabolic syndrome.Obesity and obstructive sleep apnea: pathogenic mechanisms and therapeutic approachesA randomized, controlled trial of the effects of rosiglitazone on adipokines, and inflammatory and fibrinolytic markers in diabetic patients: study design and protocol.Amino acid-sensing mTOR signaling is involved in modulation of lipolysis by chronic insulin treatment in adipocytesAdipocytokines in systemic lupus erythematosus: relationship to inflammation, insulin resistance and coronary atherosclerosis.Serum resistin concentrations and risk of new onset heart failure in older persons: the health, aging, and body composition (Health ABC) studyNutrition and health: guidelines for dental practitioners.The accelerator hypothesis: a review of the evidence for insulin resistance as the basis for type I as well as type II diabetes.Genetic polymorphisms in adipokine genes and the risk of obesity: a systematic review and meta-analysis.The effect of metformin on insulin resistance and exercise parameters in patients with heart failure.Histological Changes on Liver Glycogen Storage in Mice (Mus musculus) Caused by Unbalanced Diets.The role of leptin in the etiopathogenesis of anorexia nervosa and bulimia.Exogenous Adipokine Peptide Resistin Protects Against Focal Cerebral Ischemia/Reperfusion Injury in Mice.Resistin, visfatin, leptin and omentin are differently related to hormonal and metabolic parameters in growth hormone-deficient children.BMI and serum lipid parameters predict increasing risk and aggressive prostate cancer in Chinese people.Lipid accumulation in overweight type 2 diabetic subjects: relationships with insulin sensitivity and adipokines.Effect of body weight loss and normalization on blood pressure in overweight non-obese patients with stage 1 hypertension.Circulating resistin levels in essential hypertension.beta(3) Adrenergic receptor polymorphism and obesity-related phenotypes in hypertensive patients.
P2860
Q26765503-62761C0E-3413-41B0-966F-6D39135BE7C7Q27023149-CDCD0363-CB80-49CA-A659-B39A606295BEQ33231726-6037D977-CA3D-4865-988E-0FF0681125C6Q33609022-97674865-BEE3-4254-8D38-28B1162E46CDQ33692626-B65BF7C1-A272-4D3F-820F-C378661BD7BEQ33697471-EFFF810A-C2F5-45B5-9B56-48F75F9DCBF9Q34033575-86BB5B5C-2159-4CC4-B579-FCEFB049AE56Q34078096-D8AD3BE2-B900-49EA-80CA-622A88570EB5Q34312762-95F416A2-A08C-4F55-96E5-940ED2A725C5Q34349236-F0A38D8D-59DE-4496-A53C-9C23C49E6FABQ34369569-0BEC76E3-B418-4103-B45A-B728ADED3BC5Q34410318-06090DE2-C84C-40C3-BB8E-93A819DD06CFQ34483670-0EEFBC87-7ACA-4A1F-8047-7F7E22F0AE63Q34501403-A28377BD-4863-409B-909A-EEC554908524Q34974967-9EB9658D-ED09-4996-A7B7-2B6205654E05Q35046039-43B60FFD-5158-493B-B8A9-2B59D69E03DFQ35581618-8D114338-B05D-4DA8-BA02-662417CA5BFAQ36107200-119D1518-21A5-42BE-BFAE-2A0748442A2BQ36176430-E8CFC4ED-8485-4EE1-90FB-67023C21A90DQ36393523-9956CA65-F379-4A73-8E4E-14F25D23B182Q36741853-164ACDAF-37A6-404C-BEC2-7F789078C60BQ37072216-411D6610-D11E-44E6-BF77-A2266F99D4F5Q37077157-57524E7D-E38D-4AEF-97F6-25824A9639A2Q37098328-D2F10149-2EFB-4B6F-8177-91254236B47AQ37162256-32278B8D-59DA-40D5-A9A6-464C9030C35BQ37255236-AC5BC9FF-BB7A-45BF-9AE8-458C872BC593Q37375897-3DE6CDAC-DFDD-451E-A604-345ED92DB012Q37494751-26341872-6EFE-404D-802E-900DB05E96ADQ37511687-83E6533C-620E-4F37-BCAF-86ED539C7B7DQ37887497-2DE2910B-A06E-457B-AB31-0263DA9ED1BBQ38022224-E42B00B6-1937-4271-9D36-5003CF7D107EQ38253892-FE1DF8EC-3194-41E8-A778-B16147F367AAQ38352267-F050AD29-4B17-4C2E-9AD0-A28DAE76AEFBQ38728401-E71FEC6C-F9AF-4FA7-8433-28F96A464BDAQ39812280-D430A44A-6A49-4A93-B6BA-D38E563374B3Q42371605-808B07DB-62E1-48D2-AB53-5F5796AD1124Q42499875-ABD082FA-2777-4C41-BCF2-04867A850AFCQ43193916-A92BF413-0D27-4B2B-ABC7-6815A0709A11Q44597118-CFA9E3CF-73D2-4472-9AD4-7BF91D893463Q44741702-1369ABDE-C543-4C7E-AB26-3175CCF9C7EA
P2860
Resistin, obesity, and insulin resistance--the emerging role of the adipocyte as an endocrine organ.
description
2001 nî lūn-bûn
@nan
2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Resistin, obesity, and insulin ...... ipocyte as an endocrine organ.
@ast
Resistin, obesity, and insulin ...... ipocyte as an endocrine organ.
@en
Resistin, obesity, and insulin ...... ipocyte as an endocrine organ.
@nl
type
label
Resistin, obesity, and insulin ...... ipocyte as an endocrine organ.
@ast
Resistin, obesity, and insulin ...... ipocyte as an endocrine organ.
@en
Resistin, obesity, and insulin ...... ipocyte as an endocrine organ.
@nl
prefLabel
Resistin, obesity, and insulin ...... ipocyte as an endocrine organ.
@ast
Resistin, obesity, and insulin ...... ipocyte as an endocrine organ.
@en
Resistin, obesity, and insulin ...... ipocyte as an endocrine organ.
@nl
P1476
Resistin, obesity, and insulin ...... ipocyte as an endocrine organ.
@en
P304
P356
10.1056/NEJM200111013451814
P407
P577
2001-11-01T00:00:00Z